Japan’s New Requirement for Pediatric Drug Development Plans in PMDA Consultations

2025.04.08

Holograms,of,capsule;,charts,and,dna,helix,on,scientific,backdrop.

Japan’s New Requirement for Pediatric Drug Development Plans in PMDA Consultations

Introduction to Regulatory UpdateAccording to the news (PMDA 成人対象の治験相談でも「小児用医薬品の開発計画の有無を資料に記載」日薬連等に留意事項通知 | ニュ […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
Phone:+81-3-6304-5570